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The infectious agents responsible for the prion 
diseases appear to be aggregates of a modified form of 
the prion protein, PrPsc, that grow at the expense of the 
normal form, PrPC. The mechanism of the 
transformation of PrPc to PrPsc is the subject of intense 
research interest. The way in which PrPSC aggregates 
generate new nuclei also deserves attention. 
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The infectious agent responsible for scrapie appears to be 
the prion protein, which is capable of self-replication by 
some means [l-3]. While the details of the process that 
converts the normal form of the prion protein, PrPC, to the 
infectious form, PrPSc, are still controversial [3], many 
investigators suggest that a phenomenon related to nucle- 
ation is involved [2,4,5]. PrPSC, they believe, forms insolu- 
ble, protease-resistant aggregates that grow by recruiting 
the soluble, protease-sensitive form [6]. 
If nucleation is important in prion infections, a full under- 
standing of the kinetics of infection will require, in addi- 
tion to knowledge of the mechanisms of nucleation and 
growth, knowledge of the mechanisms of secondary (het- 
erogeneous) nucleation that enable one nucleus to gener- 
ate daughter nuclei. Although, in the case of the prion 
diseases, mechanisms of replication attract most attention, 
secondary nucle ation may be of considerable importance. 
A loose analogy may be drawn with metastasis in cancer. 
Carcinogenesis attracts the attention of the majority of 
Figure 1 
Primary and secondary nucleation. 
(a) Primary nucleation occurs when several 
monomers aggregate. (b) Secondary 
nucleation is a result of buds forming on and 
then detaching from pre-existing aggregates. 
The increase in the number of aggregates 
gives the reaction an autocatalytic nature. 
The geometric details should not be 
taken literally. 
researchers, but metastases account for the majority of 
cancer deaths. 
The phenomenon of secondary nucleation is illustrated in 
a striking fashion by a supersaturated aqueous solution of 
an inorganic salt, sodium chlorate [7]. If the solution is 
allowed to stand undisturbed in a beaker it deposits a 
mixture of enantiomorphic D and L crystals in roughly 
equal number. However, if the solution is stirred vigor- 
ously while it is crystallizing, all of the crystals formed in 
any one experiment have the same handedness, and they 
are equally likely to be all-L or all-D isomers. Vigorous stir- 
ring presumably fragments the first primary nucleus 
formed. The secondary nuclei produced in this way grow 
and are, in turn, fragmented. Before a second primary 
nucleus has time to form, the beaker fills with crystals 
‘cloned’ from the first nucleus. Since D-nuclei and 
L-nuclei ‘breed true’, one might have been inclined to call 
the D and L enantiomorphs ‘strains’ if they were not 
simple inorganic structures. 
A secondary (heterogeneous) nucleation model has 
already been developed in detail to explain unusual fea- 
tures of the kinetics of the polymerization of sickle-cell 
haemoglobin [S]. The autocatalytic nature of the reaction 
is explained by the ever-increasing area of surface on 
which new nuclei can form. This model, in a somewhat 
modified form (Fig. l), illustrates one of the many ways in 
which a prion aggregate could replicate and spread. 
The efficiency of secondary nucleation of prion aggregates 
is likely to be one of the factors that determines the 
details of the pathology of the prion diseases. If secondary 
nucleation does not occur, each nucleus introduced from 
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outside or formed endogenously grows to form a single 
localized plaque. Would this cause disease? If secondary 
nucleation is very efficient, no localized plaques might 
form even at a late stage in the disease process. The sever- 
ity of disease might be determined by the number of 
nuclei, many of which could be invisible, rather than by 
the total amount of nucleate. The mechanisms controlling 
the rate of secondary nucleation need to be investigated. 
First, it is necessary to confirm that secondary nucleation is 
a fact rather than a fantasy. As infectious scrapie can be 
transmitted serially to successive generations of animals, 
the total amount of scrapie agent and the total number of 
plaques can certainly grow exponentially. But does the 
number of plaques increase in the brain or in the test-tube? 
It is possible, in theory, that the increase in the number of 
nuclei is achieved by fragmentation during handling of the 
infectious agent. This seems unlikely, but the possibility 
should be excluded. 
If the relevance of secondary nucleation is firmly estab- 
lished, it will be important to discover the mechanism that 
leads to the formation of secondary nuclei. Does the pro- 
duction of secondary nuclei involve enzymes, such as pro- 
teases, or can it be explained by budding and related 
phenomena familiar to colloid chemists? Does secondary 
nucleation occur in the cytoplasm, in lysosomes, in associ- 
ation with membranes, or in the space between cells? 
To sustain an infectious process, newly formed nuclei 
must migrate to and become fixed at sites where they can, 
in turn, grow and throw off new daughter nuclei. Much is 
already known about the movement of infectious material 
along axons [9] and about the site-specificity of the differ- 
ent scrapie strains [lo]. Does diffusion in the space 
between cells also contribute to the spread? What propor- 
tion of new nuclei are degraded or lost in other ways 
before they can attach at productive sites? 
I do not see how to apply the methods of molecular 
biology to these problems. Microscopy seems the most 
promising approach. The way in which the distribution of 
plaque size and the number of observable plaques 
changes with time after infection might distinguish 
between simple growth of a fixed number of primary sites 
and an exponentially increasing production of new sites. 
Microscopy (or electron microscopy) might reveal incipi- 
ent nuclei, and indicate the favored sites for their forma- 
tion and the mechanism by which they are generated. Are 
there any relevant data in the literature that could be 
interpreted to throw light on secondary nucleation? 
Finally, are there non-infectious degenerative conditions 
in which amyloid plaques grow as efficiently and by essen- 
tially the same autocatalytic mechanism as in the scrapie- 
like diseases, but fail to generate new plaques? The 
critical difference between infectious and non-infectious 
agents may sometimes depend on the efficiency or ineffi- 
ciency of secondary nucleation, rather than on the rates of 
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